| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |